These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38416455)

  • 1. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
    Wang Y; Zhang L; Zheng J; Li X; Chen L
    JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
    Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
    Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
    [No Abstract]   [Full Text] [Related]  

  • 3. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
    Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
    Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 6. Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
    Megna M; Potestio L; Di Caprio N; Tajani A; Fabbrocini G; Annunziata A
    Dermatol Ther; 2022 May; 35(5):e15423. PubMed ID: 35261135
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases.
    Langer N; Wilsmann-Theis D; Kromer C; Mohr J; Mössner R
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1504-1507. PubMed ID: 34581001
    [No Abstract]   [Full Text] [Related]  

  • 8. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis].
    GRANELLI U
    Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185
    [No Abstract]   [Full Text] [Related]  

  • 10. Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report.
    Orsini D; Iacovelli P; Frascione P; Pacifico A
    J Dermatolog Treat; 2023 Dec; 34(1):2229468. PubMed ID: 37381703
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
    Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
    Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day.
    Kan Y; Uhara H
    J Dermatolog Treat; 2024 Dec; 35(1):2316239. PubMed ID: 38387442
    [No Abstract]   [Full Text] [Related]  

  • 13. Image Gallery: Pemphigus vulgaris mimicking acrodermatitis continua of Hallopeau.
    Chen Q; Du J; Jin J; Zhang J
    Br J Dermatol; 2020 Apr; 182(4):e115. PubMed ID: 31742663
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.
    Ruggiero A; Patruno C; Napolitano M; Megna M; Gisonni P; Cirillo T; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14046. PubMed ID: 32700773
    [No Abstract]   [Full Text] [Related]  

  • 15. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrodermatitis continua Hallopeau successfully treated by risankizumab.
    Hugo J; Gkalpakioti P; Arenbergerova M; Arenberger P; Gkalpakiotis S
    Int J Dermatol; 2021 Apr; 60(4):e144-e145. PubMed ID: 33368238
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar.
    Megna M; Fabbrocini G; Costa C; Ferrillo M
    Dermatol Ther; 2020 May; 33(3):e13327. PubMed ID: 32220123
    [No Abstract]   [Full Text] [Related]  

  • 19. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local injection of micro-dose guselkumab for acrodermatitis continua of Hallopeau after failure of systemic ixekizumab treatment.
    Wang Y; Zhou C; Hou Y; Diao Z; Chen D; Yin Z
    Int J Dermatol; 2024 Apr; 63(4):547-548. PubMed ID: 38228398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.